Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 19, 2025 | Huw Jones Chief Executive Officer | xxxxxxxxxxxxx | £5000 |
| Feb 19, 2025 | Toni Hänninen Chief Financial Officer | xxxxxxxxxxxxx | £5000 |
| Feb 19, 2025 | Nick Mallard Vice President Of Product Management | xxxxxxxxxxxxx | £3000 |
| Feb 19, 2025 | Glen Clack Chief Medical Officer | xxxxxxxxxxxxx | £5000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Evgen Pharma PLC (GB:TCF)?
Currently, no data Available
What percentage of Evgen Pharma PLC (GB:TCF) stock is held by institutional investors?
Currently, no data Available
What percentage of Evgen Pharma PLC (GB:TCF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Evgen Pharma PLC (GB:TCF)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.